ArticlePediatrics2026
Enteric Viral Pathogens in Infants in the United States: 2017-2020.
Article in Pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Symptomatic and Asymptomatic Norovirus Infections in Early Life; the PREVAIL Cohort, 2017-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
Corrections and comments
- Commented on by
Authors and funding
18 authors.
Funding
Abstract
objectiveThe introduction of rotavirus vaccines in the United States led to substantial reductions in rotavirus disease burden, whereas the relative burden of other viral pathogens causing acute gastroenteritis (AGE) increased. Our aim was to establish the community-level burden of enteric viral pathogens in a US cohort during the first 2 years of life.
methodsFrom birth until age 2 years, weekly stools and AGE symptom surveys were collected from mother-child pairs in the PREVAIL (Pediatric Respiratory & Enteric Virus Acquisition and Immunogenesis Longitudinal) cohort. Stools were tested for 5 enteric viral pathogens, with infections defined by grouping proximal viral detections with the same genotype. Rates of infection and AGE symptoms were determined.
resultsFrom 2017 to 2020, 245 children were followed, with 13 944 stools tested and 836 episodes of AGE recorded. Children had 3.8 enteric viral infections per child-year and over two-thirds had 1 or more symptomatic enteric viral infection by age 2 years. Norovirus Genogroup II (0.4 per child-year) and sapovirus (0.2 per child-year) had the highest incidence of symptomatic infections, followed by astrovirus, rotavirus, norovirus Genogroup I, and adenovirus 40/41 (each ≤0.1 per child-year). Approximately two-thirds of enteric viral infections were asymptomatic, and 90% were not medically attended. Symptomatic infections were infrequent before age 6 months.
conclusionOur findings show the high burden of symptomatic enteric viral infections, particularly norovirus, as well as the high frequency of asymptomatic infections, thereby improving our understanding of the epidemiology and clinical manifestations of enteric viral infections in young US children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.